Rating:

Loading...

A Pharmacy Icon Looks to the Future

Kevin J. Colgan, M.A., FASHP

ASHP WILL LOSE A VENERABLE GIANT of the profession to retirement in a few years, and I felt that it was important to acknowledge this significant transition. You may already have heard that ASHP’s esteemed EVP and CEO Henri R. Manasse, Jr., Ph.D., Sc.D., recently announced his retirement as of June 30, 2011.

This dedicated ASHP executive has worked tirelessly for more than a decade to provide big-picture thinking about the future of the profession. He is a passionate, eloquent advocate of medication safety. And he has proffered exceptional leadership to ASHP’s Board of Directors; councils, committees, and House of Delegates; and staff members along the way.

Perhaps the most important contribution Henri has made—and continues to make—to ASHP and its members is his important work in raising the visibility of the Society exponentially among other healthcare organizations, both in the U.S. and internationally. A fixture in the hospital and health-system pharmacy world, Henri is well-known in national healthcare, legislative, and regulatory circles.

From the National Patient Safety Foundation, the Institute of Medicine, and the Food & Drug Administration to The Joint Commission, Congress, and International Pharmaceutical Federation—and all points in between—Henri has had measurable impact on educating others about the value pharmacists bring to patient care and quality outcomes.

Henri continues to serve all of us well as the voice of ASHP and health-system pharmacy practice. I, for one, deeply value the friendship we’ve enjoyed over the years, and I look forward to our work together this year and into the future.

Kevin J. Colgan, M.A., FASHP